Continuous subcutaneous insulin infusion methods with a hyaluronan-degrading enzyme
申请人:Vaughn Daniel Edward
公开号:US20130022592A1
公开(公告)日:2013-01-24
Provided are methods for continuous subcutaneous insulin infusion (CSII) that employ a hyaluronan-degrading enzyme, including a recombinant human PH20 (rHuPH20). The methods can be used to more consistently control blood glucose during the course of CSII. The methods can be used to treat subjects having diabetes or other insulin-associated disease or condition.